SCIMED
SCIMED, officially known as SCIMED Life Sciences, is a prominent player in the biotechnology industry, headquartered in the United States. Founded in 2010, the company has established itself as a leader in developing innovative medical devices and diagnostic solutions, primarily serving the healthcare sector across North America and Europe. SCIMED's core offerings include advanced imaging systems and precision instruments that enhance clinical outcomes and streamline workflows. What sets SCIMED apart is its commitment to integrating cutting-edge technology with user-friendly designs, ensuring that healthcare professionals can deliver optimal patient care. With a strong market position, SCIMED has achieved significant milestones, including numerous patents and partnerships with leading healthcare institutions. The company continues to drive advancements in medical technology, solidifying its reputation as a trusted name in life sciences.
DitchCarbon Score
How does SCIMED's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Computer Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
SCIMED's score of 25 is higher than 89% of the industry. This can give you a sense of how well the company is doing compared to its peers.
SCIMED's reported carbon emissions
In 2023, SCIMED reported total carbon emissions of approximately 227,777,000 kg CO2e across all scopes. This figure includes 10,889,000 kg CO2e from Scope 1, 701,000 kg CO2e from Scope 2, and a significant 227,777,000 kg CO2e from Scope 3 emissions. Over the years, SCIMED has demonstrated a commitment to reducing its carbon footprint. From 2019 to 2023, the company has achieved a notable decrease in Scope 1 emissions from 12,828,000 kg CO2e to 10,889,000 kg CO2e, and Scope 2 emissions have also decreased from 21,919,000 kg CO2e to 701,000 kg CO2e. However, Scope 3 emissions have seen fluctuations, with a peak of 296,337,000 kg CO2e in 2019, reducing to 227,777,000 kg CO2e in 2023. Despite these reductions, SCIMED has not publicly committed to specific science-based targets or documented reduction initiatives. The company continues to monitor its emissions and engage in climate-related efforts, reflecting an awareness of its environmental impact.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
Add to project| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Scope 1 | 12,828,000 | 00,000,000 | 0,000,000 | 00,000,000 | 00,000,000 |
| Scope 2 | 21,919,000 | 00,000,000 | 0,000,000 | 0,000,000 | 000,000 |
| Scope 3 | 296,337,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
SCIMED is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
